DOI: https://doi.org/10.22141/2308-2097.53.1.2019.163459

Pathogenetic aspects of chronic pancreatitis and chronic obstructive pulmonary disease comorbidity

T.N. Hristich, D.O. Hontsariuk

Abstract


A review of the literature considers the question of the involvement of certain mechanisms in the comorbid course of chronic pancreatitis with chronic obstructive pulmonary disease (COPD). Attention is drawn to the fact that the common mechanisms of development can reveal the essence of adaptation processes or serve for their use in developing strategies and treatments, prevention and rehabilitation of patients in polymorbidity with an individual approach. The authors attempted to consider the development and progression of diseases from the perspective of theory of syntropic and interfe­rence mechanisms. Significance of oxidative stress, chronic systemic inflammation (including C-reactive protein in the development of insulin resistance), endothelial dysfunction, microcirculatory disorders and hypoxia was considered. Emphasis is placed on the fact that microcirculatory disorders and hypoxia, as well as C-reactive protein effect on the formation of insulin resistance can be considered as transsyndromal mechanisms in comorbid flow of chronic pancreatitis with COPD. This is important for the tactics and strategy of medical rehabilitation activities conducted in patients suffering from chronic pancreatitis with COPD, as it prevents polypharmacy.

Keywords


chronic pancreatitis; chronic obstructive pulmonary disease; syntropy; transsyndromicity; chronic systemic inflammatory response; hypoxia; review

References


Paleev FN, Abudeeva IS, MoskaletsOV, Minchenko BI, Belokopytova IS. Non specific markers of inflammation in prognostication of the course of ischemic heart disease. Kardiologiia. 2009;49(9):59-65. (in Russian).

Sannikova MV, Klementova SV, VakhrushevIa V. Clinical and functional characteristics of the pancreas due to chronic obstructive pulmonary disease. Eksperimental'naia I klinicheskaia gastroenterologiia. 2007;(6):35-37. (in Russian).

Teleki JM, Khrystych TM, Olinyk OJu, Goncarjuk DO. The level of growth factor in patients with chronic obstructive disease with concomitant chronic pancreatitis. In: Proceeding of the Scientificand Practical Conference on Metabolic syndrome: a multidisciplinary approach, dedicated to the 95th anniversary of Professor Samson EI birth. 2016 April 14-15; Chernivtsi, Ukraine. Chernivtsi; 2016. 115-116 pp. (in Ukraininan).

Afanas'jev SV, Lyholat OA. Regional features of free radical oxidation of lipids and antioxidant system in patients with chronic pancreatitis. Medical Chemistry. 2005;7(1):33-36. (in Ukrainian).

Kunisaki KM, Rice KL, Janoff EN, Rector TS, Niewoehner DE. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study. Ther Adv Respir Dis. 2008 Apr;2(2):55-64. doi: 10.1177/1753465808088902.

Khrystych TM, Teleki JM, Fediv OI, Olinyk OJu. Hronichne obstruktyvne zahvorjuvannja legen' ta hronichnyj pankreatyt: klinichno-patogenetychni osoblyvosti rozvytku pojednanyh zahvorjuvan' ta metody medykamentoznoi' korekcii' [Chronic obstructive pulmonary disease and chronic pancreatitis: clinical and pathogenetic features of the development of combined diseases and methods of drug correction]. Chernivtsi; 2013. 232 p. (in Ukrainian).

Khrystych TM. About the pathogenesis of combined diseases of digestive tract and bronchopulmonary systems: literature review. Ukraïnskij medicnij alʹmanah. 2006;9(2):223-226. (in Russian).

Khrystych TM, Teleki JM, Djak MV, Denysenko TP. C-reactive protein content in patients with chronic obstructive pulmonary disease with concomitant chronic pancreatitis. Gastroenterologija. Mizhvidomchyj zbirnyk. 2010;(44):240-244. (in Ukrainian).

Teleki J, Khrystych T, Fediv O, Olinyk O, Bagrij V. Comprehensive assessment of the quality of life of patients with chronic pancreatitis on the background of chronic obstructive pulmonary disease. In: Proceeding of the 45th Meeting of European Pancreatic Club on Pancreatology. 2013 June 20-23; Prague, Czech Republic. Prague; 2013. 537 p.

Viun TI, Pasiyeshvili LM. Priorities of the diagnostic search for osteopenic conditions in patients with chronic pancreatitis and hypertensive disease. Modern Gastroenterology. 2018;(101):14-20. (in Russian).

Khrystych TM, Kushnir LD, Goncarjuk DO, Teleki JM, Bagriy VN. About the mechanisms affecting formation of heart failure in chronic lungs obstructive patients. Achievements of clinical and experimental medicine. 2017;(31):6-12. (in Russian).

Todorіko LD. Pathogenetic characteristic of progression of systemic inflammation in chronic obstructive pulmonary diseases in the elderly and old age. Ukrainian therapeutical journal.2010;(26):107-112. (in Ukrainian).

Pertseva TO, Konopkina LI. The role of systemic inflammatory markers in formation of immune responce on infection/colonization in chronic obstructive pulmonary disease patients. Ukrainian Pulmonology Journal. 2007;(1):22-25. (in Ukrainian).

Serebrennikova SN, Seminsky IZh. The role of cytokines in the inflammatory process (Part 1). Sibirskij Medicinskij Zurnal (Irkutsk). 2008;(6):5-8. (in Russian).

De Torres JP, Pinto-Plata V, Casanova C, et al. C-reactive protein levels and survival in patients with moderate to very severe COPD. Chest. 2008 Jun;133(6):1336-1343. doi: 10.1378/chest.07-2433.

Teleki JM, Khrystych TM, Dudko JuO. Effect of treatment on the status of the antioxidant protection system indicators and oxidative stress in chronic obstructive lung disease in combination with chronic pancreatitis. The Unity of Science. 2015;(3):202-206. (in Russian).

Olіnyk ОJu, Fedіv OІ, Davydenko ІS, Ginguliak MO. The functional condition of the endothelium in patients with peptic ulcer of the stomach and duodenum, combined with diabetes mellitus. Buk Med Herald. 2010;14(56):66-69. (in Ukrainian).

Khrystych TM, Telekі JM, Kushnіr LD. Vascular endothelial dysfunction in patients with chronic obstructive pulmonary disease with concomitant chronic pancreatitis. Gastroenterologija. Mizhvidomchyj zbirnyk. 2009;(42):267-270. (in Ukrainian).

Kubysheva NI, Postnikova LB, Presniakova NB, et al. Soluble antigens ICAM 1 m sICAM in chronic obstructive pulmonary disease. Immunopatologiia i klinicheskaia immunologiia. 2009;(1):55-57. (in Russian).

Teleki JM, Scherbinina MB, Masliy NK, Vivsiana IA, Dybel OV, Hodan AI. The cytokine status and endothelial functioning in the group of patients with cronic obstructive pulmonary desease and concomitant chronic pancreatitis in the dynamic of treatment. The Unity of Science. 2016;(2):106-110. (in Russian).

Khrystych TM, Temerivska TG, Goncarjuk DO. Hronichnyj pankreatyt: suchasnyj pogljad na etiologiju, patogenez, kliniku, likuvannja ta medychnu reabilitaciju hvoryh na hronichnyj pankreatyt: metodychni rekomendacii' [Chronic pancreatitis: a modern view on the etiology, pathogenesis, clinic, treatment and medical rehabilitation of patients with chronic pancreatitis: guidelines]. Chernivtsi; 2018. 172 p. (in Ukrainian).

Khrystych TM. Khronicheskoe legochnoe serdtse: sovremennye kontseptsii [Chronic pulmonary heart: modern concepts]. Chernivtsi: Knygy ХХІ; 2009. 368 p. (in Russian).

Taubert D, Rosenkranz A, Berkels R, Roesen R, Schömig E. Acute effects of glucose and insulin on vascular endothelium. Diabetologia. 2004 Dec;47(12):2059-71. doi: 10.1007/s00125-004-1586-1.

Zemlyak OS, Babіnets LS. Metabolic acidosis as an important factor of pathogenesis of chronic pancreatitis. Visnyk klubu pankreatologiv. 2018;(40):17-19. (in Ukrainian).

MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(1):50-60. doi: 10.1513/pats.200411-056SF.

Travina EV, Khrenov AA. The formation of a Th1-associated type of cytokine imbalance in the development of metabolic syndrome in patients with COPD. Tavriceskij mediko-biologiceskij vestnik. 2012;15(2):234-238. (in Russian).

Amrani Y, Lazaar AL, Hoffman R, Amin K, Ousmer S, Panettieri RA Jr. Activation of p55 tumor necrosis factor-alpha receptor-1 coupled to tumor necrosis factor receptor-associated factor 2 stimulates intercellular adhesion molecule-1 expression by modulating a thapsigargin-sensitive pathway in human tracheal smooth muscle cells. Mol Pharmacol. 2000 Jul;58(1):237-45.

Teleki JM, Khrystych TM. Vascular endothelial function in patients with chronic obstructive pulmonary disease with concomitant chronic pancreatitis. Gastroenterologia Sankt-Peterburga. 2017;(2):55-58. (in Russian).

Quon BS, Gan WQ, Sin DD. Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis. Chest. 2008 Mar;133(3):756-66. doi: 10.1378/chest.07-1207.

Samoylenko AA. The role of hypoxia-inducible proteines family (HIF) in the regulation of cells physiologic responses to hypoxia. The Ukrainian Biochemical Journal. 2010;82(4):5-17. (in Ukrainian).

Cheng K, Ho K, Stokes R, et al. Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets. J Clin Invest. 2010 Jun;120(6):2171-83. doi: 10.1172/JCI35846.

Halberg N, Khan T, Trujillo ME, et al. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol. 2009 Aug;29(16):4467-83. doi: 10.1128/MCB.00192-09.

Burt MG, Roberts GW, Aguilar-Loza NR, Frith P, Stranks SN. Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD. J Clin Endocrinol Metab. 2011 Jun;96(6):1789-96. doi: 10.1210/jc.2010-2729.

Spies CM, Strehl C, van der Goes MC, Bijlsma JW, Buttgereit F. Glucocorticoids. Best Pract Res Clin Rheumatol. 2011 Dec;25(6):891-900. doi: 10.1016/j.berh.2011.11.002.

Brock C, Nielsen LM, Lelic D, Drewes AM. Pathophysiology of chronic pancreatitis. World J Gastroenterol. 2013 Nov 14;19(42):7231-40. doi: 10.3748/wjg.v19.i42.7231.

Pohl D, Savarino E, Hersberger M, et al. Excellent agreement between genetic and hydrogen breath tests for lactase deficiency and the role of extended symptom assessment. Br J Nutr. 2010 Sep;104(6):900-7. doi: 10.1017/S0007114510001297.

Khrystych TM, Fediv AI, Iliushyna AA, Teleki JM, Oliinyk OYu. Chronic obstructive pulmonary disease: heterogeneity of the course (literature review). Buk Med Herald. 2012;(62):174-178. (in Ukrainian).

Khrystych TM, Fediv OI, Teleki JM, Olіnyk ОJu, Goncarjuk DO. Hronichnyj pankreatyt: klinichno-patogenetychni osoblyvosti pojednannja z zahvorjuvannjamy vnutrishnih organiv ta metody medykamentoznoi' korekcii' [Chronic pancreatitis: clinical and pathogenetic features of combination with diseases of internal organs and methods of medical correction]. Chernivtsi; 2017. 248 p. (in Ukrainian).

Khrystych TM. Non-alcoholic fatty liver disease: the possibilities of drug correction. Novosti Meditsiny i Farmatsii. 2014;(509):10-12. (in Ukrainian).




Copyright (c) 2019 GASTROENTEROLOGY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2019

 

   Seo анализ сайта